A selective serotonin reuptake inhibitor (SSRI) - induced case of catathrenia
Sleep Medicine · 2026
DOI: 10.1016/j.sleep.2026.109098 ↗Kurz gefasst
Fallbericht in der Zeitschrift Sleep Medicine, 2026. Verfasst von Pasquale Tondo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Function and Sleep Medicine Unit, Istituti Clinici Scientifici "Maugeri" IRCCS, Scientific Institutes of Montescano and Pavia, Pavia, Ita…. Hauptthemen laut MEDLINE: Selective Serotonin Reuptake Inhibitors, Parasomnias. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Catathrenia is currently classified as a sleep-related breathing disorder characterized by a deep inspiration followed by a prolonged, groaning expiration. While antidepressant- and antipsychotic-induced akathisia and restless legs syndrome (RLS) are well-documented, the potential for these medications to trigger catathrenia remains unrecognized. Selective serotonin reuptake inhibitors (SSRIs) are known to exacerbate or induce various sleep disturbances, including periodic leg movement disorder (PLMD), RLS, bruxism, and REM sleep without atonia. However, an association between SSRIs and catathrenia has not yet been reported. Here, we present the first documented case of catathrenia induced by SSRI therapy in a patient with coexisting obstructive sleep apnea.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Respiratory Function and Sleep Medicine Unit, Istituti Clinici Scientifici "Maugeri" IRCCS, Scientific Institutes of Montescano and Pavia, Pavia, Italy; Respiratory Medicine Unit, Department of Medical and Surgical Scie…
- Respiratory Function and Sleep Medicine Unit, Istituti Clinici Scientifici "Maugeri" IRCCS, Scientific Institutes of Montescano and Pavia, Pavia, Italy.
- Sleep Medicine, Parma, Italy.
- Respiratory Function and Sleep Medicine Unit, Istituti Clinici Scientifici "Maugeri" IRCCS, Scientific Institutes of Montescano and Pavia, Pavia, Italy. Electronic address: francesco.fanfulla@icsmaugeri.it.
Zitieren
APA
Tondo, P., Perretti, C., Di Giorgi, F., Gianfrate, M., Parrino, L., & Fanfulla, F. (2026). A selective serotonin reuptake inhibitor (SSRI) - induced case of catathrenia. Sleep Medicine. https://doi.org/10.1016/j.sleep.2026.109098
Vancouver
Tondo P, Perretti C, Di Giorgi F, Gianfrate M, Parrino L, Fanfulla F. A selective serotonin reuptake inhibitor (SSRI) - induced case of catathrenia. Sleep Medicine. 2026. doi:10.1016/j.sleep.2026.109098
BibTeX
@article{Tondo2026,
author = {Tondo, Pasquale and Perretti, Carlo and Di Giorgi, Federica and Gianfrate, Michele and Parrino, Liborio and Fanfulla, Francesco},
title = {A selective serotonin reuptake inhibitor (SSRI) - induced case of catathrenia},
journal = {Sleep Medicine},
year = {2026},
doi = {10.1016/j.sleep.2026.109098}
}
EUVIMED